These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 29566993

  • 1. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells.
    Li P, Li Q, Zhang Y, Sun S, Liu S, Lu Z.
    Biomed Pharmacother; 2018 Aug; 104():832-840. PubMed ID: 29566993
    [Abstract] [Full Text] [Related]

  • 2. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer.
    Zheng GX, Qu AL, Yang YM, Zhang X, Zhang SC, Wang CX.
    World J Gastroenterol; 2016 Jun 28; 22(24):5589-97. PubMed ID: 27350737
    [Abstract] [Full Text] [Related]

  • 3. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T, Cai X, Li Q, Xue P, Chen Z, Dong X, Xue Y.
    Oncotarget; 2016 Jul 05; 7(27):42225-42240. PubMed ID: 27302926
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ, Shen L, Yu J.
    Oncogene; 2015 Jul 30; 34(31):4142-52. PubMed ID: 25362853
    [Abstract] [Full Text] [Related]

  • 6. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L, Yao J, Qiu J.
    Biomed Pharmacother; 2017 Dec 30; 96():974-981. PubMed ID: 29221726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
    Rasmussen MH, Lyskjær I, Jersie-Christensen RR, Tarpgaard LS, Primdal-Bengtson B, Nielsen MM, Pedersen JS, Hansen TP, Hansen F, Olsen JV, Pfeiffer P, Ørntoft TF, Andersen CL.
    Nat Commun; 2016 Aug 16; 7():12436. PubMed ID: 27526785
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
    Wang B, Shen ZL, Jiang KW, Zhao G, Wang CY, Yan YC, Yang Y, Zhang JZ, Shen C, Gao ZD, Ye YJ, Wang S.
    BMC Cancer; 2015 May 28; 15():437. PubMed ID: 26016795
    [Abstract] [Full Text] [Related]

  • 11. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L.
    Eur J Cancer; 2013 Dec 28; 49(18):3924-35. PubMed ID: 23968734
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S, Li W, Sun H, Wu B, Ji F, Sun T, Chang H, Shen P, Wang Y, Zhou D.
    BMC Cancer; 2015 Dec 16; 15():969. PubMed ID: 26674205
    [Abstract] [Full Text] [Related]

  • 13. Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
    Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K, Kiss I, Vyzula R, Slaby O.
    J Cell Mol Med; 2012 Nov 16; 16(11):2655-66. PubMed ID: 22469014
    [Abstract] [Full Text] [Related]

  • 14. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S, Liu H, Hou S, Wu L, Yang Z, Shen J, Zhou L, Zheng SS, Jiang B.
    Clin Transl Oncol; 2018 Jun 16; 20(6):703-712. PubMed ID: 29071516
    [Abstract] [Full Text] [Related]

  • 15. The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.
    Tang W, Zhou W, Xiang L, Wu X, Zhang P, Wang J, Liu G, Zhang W, Peng Y, Huang X, Cai J, Bai Y, Bai L, Zhu W, Gu H, Xiong J, Ye C, Li A, Liu S, Wang J.
    Nat Commun; 2019 Feb 08; 10(1):663. PubMed ID: 30737378
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L, Li X, Zhang X, Lv Z, He G, Zhao W, Ren X, Li Y, Bian X, Liao W, Liu W, Yang G, Ding Y.
    Gastroenterology; 2013 Mar 08; 144(3):624-635.e4. PubMed ID: 23201162
    [Abstract] [Full Text] [Related]

  • 17. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
    Sun D, Wang C, Long S, Ma Y, Guo Y, Huang Z, Chen X, Zhang C, Chen J, Zhang J.
    Br J Cancer; 2015 Apr 28; 112(9):1491-500. PubMed ID: 25867276
    [Abstract] [Full Text] [Related]

  • 18. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression.
    Liu W, Song Y, Zhang C, Gao P, Huang B, Yang J.
    Biomed Pharmacother; 2018 Aug 28; 104():94-101. PubMed ID: 29772445
    [Abstract] [Full Text] [Related]

  • 19. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
    Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L.
    Biochem J; 2012 Mar 01; 442(2):311-21. PubMed ID: 22132820
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec 01; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.